Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 4917 results
Intercept gets FDA breakthrough therapy status for Obeticholic acid to treat NASH with liver fibrosis
Intercept Pharmaceuticals, announced that its investigational product obeticholic acid (OCA) has received "breakthrough therapy designation" from the U.S. Food and Drug Administration (FDA) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis.
Drug Research > Drug Discovery & Development > News
Sumitomo Chemical develops SumiLarv 2 MR to prevent dengue fever
Sumitomo Chemical is pleased to announce that it has developed SumiLarv 2 MR, a novel, long - lasting larvicide formulation that is effective in preventing dengue fever.
Drug Research > Drug Discovery & Development > News
AgeneBio secures ADDF grant for new approach to delaying onset of Alzheimer's Dementia
AgeneBio, a pharmaceutical company developing innovative therapeutics for unserved patients battling amnestic mild cognitive impairment (aMCI), the pre-dementia stage of Alzheimer's disease, and other neurological and psychiatric diseases, announced that the company has received a $900,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF).
Drug Research > Drug Discovery & Development > News
CEL-SCI secures approval in Romania to start Phase III Multikine trial
By PBR Staff Writer
US-based CEL-SCI has received clearance from the Romanian Ministry of Health to start patient enrollment in its Phase III trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection) to treat advanced primary head and neck cancer.
Drug Research > Drug Discovery & Development > News
Opsona starts OPN-305 Phase I/II trial to treat myelodysplastic syndrome
By PBR Staff Writer
Opsona Therapeutics has commenced a Phase I/II clinical trial of its lead drug candidate, OPN-305, in second-line lower (Low and intermediate-1) risk myelodysplastic syndrome (MDS) patients.
Drug Research > Drug Discovery & Development > News
Extending Soft Gelatin Capsule Benefits to Novel Fixed Dose Combinations: Unigel
Fixed dose combinations are desirable for several reasons such as different release profiles and guaranteeing patientsĀ“ compliance by reducing the daily intake of a drug product(s).
Drug Research > Drug Discovery & Development > Press Releases
CytRx reports overall survival results from phase IIb trial of aldoxorubicin
CytRx, a biopharmaceutical research and development company specializing in oncology, announced encouraging overall survival (OS) results, the secondary endpoint, from its completed multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS).
Drug Research > Drug Discovery & Development > News
Curis, Aurigene partner to develop precision oncology targets
Curis and Aurigene Discovery Technologies have entered into an exclusive collaboration agreement focused on immuno-oncology and selected precision oncology targets.
Drug Research > Drug Discovery & Development > News
Tobira begins dosing in Phase I trial of cenicriviroc and pioglitazone
By PBR Staff Writer
US-based biopharmaceutical firm Tobira Therapeutics has started dosing in a Phase I trial to evaluate the pharmacokinetics and safety in healthy patients of cenicriviroc (CVC) and the diabetes medication pioglitazone, both when administered alone and in combination.
Drug Research > Drug Discovery & Development > News
Enzymotec begins 24-month clinical trial of Vayacog in MCI patients
By PBR Staff Writer
Israel-based Enzymotec has started a clinical trial to evaluate the long term efficacy of Vayacog in patients with Mild Cognitive Impairment (MCI).
Drug Research > Drug Discovery & Development > News
Caris Molecular Intelligence identifies therapeutic options for patients with ASCC
Caris Life Sciences announced the presentation of data from a study in which Caris Molecular Intelligence, the company's panomic, comprehensive tumor profiling service, identified potentially actionable alterations in patients with recurring or metastasized anal squamous cell carcinoma (ASCC), a rare human papilloma virus (HPV)-associated malignancy accounting for 2.4% of digestive system cancers.
Drug Research > Drug Discovery & Development > News
Boehringer, Sanofi partner to produce monoclonal antibodies
By PBR Staff Writer
Germany-based Boehringer Ingelheim has entered into a strategic agreement with French pharmaceutical firm Sanofi to manufacture therapeutic monoclonal antibodies.
Drug Research > Drug Discovery & Development > News
AstraZeneca reports PEGASUS-TIMI 54 trial meets primary endpoint
AstraZeneca announced that the PEGASUS-TIMI 54 study, a large scale outcomes trial involving over 21,000 patients, successfully met its primary efficacy endpoint.
Drug Research > Drug Discovery & Development > News
Merck, Moderna to develop mRNA-based antiviral vaccines and passive immunity therapies
By PBR Staff Writer
Merck and Moderna Therapeutics have agreed to a license and three-year research collaboration deal to discover and develop modified messenger RNA-based (mRNA) vaccines and passive immunity treatments against viral diseases.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
Tosoh Bioscience - Your Specialist in Separation
Tosoh Bioscience is an acknowledged global leader in the field of liquid chromatography with a strong focus on bioseparations. We offer solutions for research, drug discovery, clinical chemistry, environmental analysis, manufacturing and other industrial applications. ... Drug Research > Drug Discovery & Development > Suppliers
Medical Research Network - Clinical Trial Support Organisation
The Medical Research Network (MRN) is a unique clinical trial support organisation (CTSO). The MRN has been involved in the conduct of over 50 clinical trials across a wide range of therapeutic areas, in particular oncology and rheumatology.... Drug Research > Drug Discovery & Development > Suppliers
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

IDT Biologika - Pharmaceuticals By IDT Biologika
In the highly specialized world of sterile liquid dosage forms, IDT Biologika is a contract manufacturing organization with the experience, the capability and the commitment to excellence to offer you a strategic advantage in your commercialization process. Our expertise drives our activities into higher-value pharmaceutical and biotechnology applications.... Drug Research > Drug Discovery & Development > White Papers Freeze Drying - Large-Scale Production for Biologics By IDT Biologika
IDT's new world-class multi-purpose high-speed filling and large-scale freeze-drying plant for human vaccines (liquid and lyophilized) is equipped to handle and respond to the complex quality and safety demands of current and future live vaccines and immunotherapeutic medicines.... Drug Research > Drug Discovery & Development > White Papers IDT Biopharmaceutical Contract Manufacturing By IDT Biologika
IDT's special expertise and capabilities include: development and aseptic filling services for parenterals in syringes, vials and ampoules; proven expertise in processing of biopharmaceutical and chemical substances; leading competence in freeze drying of narcotics; and integrated bio and pharma manufacturing site with comprehensive quality control services.... Drug Research > Drug Discovery & Development > White Papers IDT Human Vaccines Contract Manufacturing By IDT Biologika
IDT produces a wide variety of vaccines for clinical testing and is also developing new technologies for many innovative and future orientated human vaccines, for instance against tuberculosis, AIDS and malaria. Over 20 different vaccines for clinical trials in humans have been handled by IDT to date.... Drug Research > Drug Discovery & Development > White Papers Vaccines - Creating Value, Protecting Lives By IDT Biologika
IDT is a knowledgeable partner and an expert in the field of biologics contract manufacturing. IDT is focused on four business segments: animal health, vaccines, pharmaceuticals and quality control. We are a vital link in the development chain of new vaccines. Our core competency is in the contract production of viral and bacterial vaccines. We offer a comprehensive portfolio of services and solutions, from development up to large-scale production.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 4917 results